United States · FDA National Drug Code directory

North American Coral Snake Antivenin (Equine)

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0008-0423_7a16fb9b-c963-48d9-90f9-b428857ab5de
Product NDC: 0008-0423
Form: INJECTION, POWDER, FOR SOLUTION
Composition / generic term: Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)
Labeler: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Marketing category: BLA
Marketing start / end (source format): 20161012
Source listing expiry: 20261231

Source-listed ingredients

CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE) — 250 [arb'U]/10mL

These values do not establish equivalence or a dose recommendation.

Packages

1 VIAL in 1 CARTON (0008-0423-03) / 10 mL in 1 VIAL (0008-0423-01) · 0008-0423-03

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →